EGFP–acVHH–PB
(Plasmid
#169685)
-
PurposeAn anti-caffeine nanobody responds to caffeine to induce dimerization of a phospholipid-binding polybasic domain with subsequent plasma membrane translocation.
-
Depositing Lab
-
Sequence Information
-
Sequences (1) — Accept Affinity Reagent Sequence Policy
-
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 169685 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonemEGFP-C1
- Backbone size w/o insert (bp) 4900
- Total vector size (bp) 5300
-
Vector typeMammalian Expression
-
Selectable markersNeomycin (select with G418)
Growth in Bacteria
-
Bacterial Resistance(s)Kanamycin, 50 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameanti-caffeine nanobody
-
SpeciesSynthetic
-
Insert Size (bp)354
- Promoter CMV
-
Tag
/ Fusion Protein
- modified STIM1-PB tag (N terminal on backbone)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site AgeI (not destroyed)
- 3′ cloning site XhoI (not destroyed)
- 5′ sequencing primer EGFPC1F: GAT CAC TCT CGG CAT GGA C
- 3′ sequencing primer SV40pA-R: GAA ATT TGT GAT GCT ATT GC (Common Sequencing Primers)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
EGFP–acVHH–PB was a gift from Yubin Zhou (Addgene plasmid # 169685 ; http://n2t.net/addgene:169685 ; RRID:Addgene_169685) -
For your References section:
Caffeine-Operated Synthetic Modules for Chemogenetic Control of Protein Activities by Life Style. Wang T, He L, Jing J, Lan TH, Hong T, Wang F, Huang Y, Ma G, Zhou Y. Adv Sci (Weinh). 2020 Dec 13;8(3):2002148. doi: 10.1002/advs.202002148. eCollection 2021 Feb. 10.1002/advs.202002148 PubMed 33552855